Total Payments
$520.01
2024 Payments
$74.99
Companies
8
Transactions
20
Medicare Patients
781
Medicare Billing
$73,261
Payment Breakdown by Category
Food & Beverage$445.02 (85.6%)
Education$74.99 (14.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $445.02 | 19 | 85.6% |
| Education | $74.99 | 1 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $166.12 | 10 | $0 (2018) |
| Lilly USA, LLC | $125.00 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $74.99 | 1 | $0 (2024) |
| PFIZER INC. | $70.27 | 3 | $0 (2020) |
| GlaxoSmithKline, LLC. | $36.80 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.91 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $16.12 | 1 | $0 (2019) |
| AbbVie, Inc. | $12.80 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.99 | 1 | Janssen Biotech, Inc. ($74.99) |
| 2023 | $125.00 | 1 | Lilly USA, LLC ($125.00) |
| 2020 | $16.82 | 1 | PFIZER INC. ($16.82) |
| 2019 | $120.60 | 6 | PFIZER INC. ($53.45) |
| 2018 | $66.69 | 4 | Celgene Corporation ($50.21) |
| 2017 | $115.91 | 7 | Celgene Corporation ($115.91) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 03/02/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Immunology | ||||||
| 10/15/2020 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2019 | PFIZER INC. | CELEBREX (Drug), LYRICA | Food and Beverage | In-kind items and services | $35.68 | General |
| Category: INFLAMMATION;ONCOLOGY;PAIN | ||||||
| 10/25/2019 | Novartis Pharmaceuticals Corporation | ILARIS (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Immunology | ||||||
| 10/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/05/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $16.58 | General |
| 01/30/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $10.70 | General |
| 01/18/2018 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $22.93 | General |
| 01/11/2018 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 08/11/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $22.18 | General |
| 05/10/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $11.62 | General |
| 03/31/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $20.55 | General |
| 03/03/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $10.72 | General |
| 02/24/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $13.40 | General |
| 02/10/2017 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $13.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 186 | 226 | $40,386 | $15,224 |
| 2022 | 4 | 198 | 274 | $40,350 | $21,472 |
| 2021 | 6 | 194 | 262 | $37,636 | $21,805 |
| 2020 | 5 | 203 | 233 | $28,410 | $14,761 |
Total Patients
781
Total Services
995
Medicare Billing
$73,261
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 70 | 90 | $17,854 | $6,464 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 90 | $14,441 | $5,684 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $4,129 | $1,360 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 21 | $2,562 | $1,095 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 12 | 12 | $1,400 | $621.48 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 180 | $27,000 | $14,844 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 53 | $6,572 | $3,380 | 51.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $6,440 | $2,942 | 45.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 13 | $338.00 | $306.02 | 90.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 183 | $27,685 | $16,415 | 59.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $4,715 | $2,591 | 54.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 21 | $2,426 | $1,322 | 54.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 11 | 11 | $880.00 | $717.86 | 81.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 11 | $1,540 | $507.27 | 32.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $390.00 | $252.00 | 64.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 74 | $10,360 | $5,169 | 49.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 70 | $6,510 | $2,967 | 45.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 31 | 33 | $4,620 | $2,578 | 55.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 37 | 40 | $3,480 | $2,221 | 63.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $3,440 | $1,826 | 53.1% |
About Dr. Terry Moore, M.D
Dr. Terry Moore, M.D is a Rheumatology healthcare provider based in St. Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114014867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terry Moore, M.D has received a total of $520.01 in payments from pharmaceutical and medical device companies, with $74.99 received in 2024. These payments were reported across 20 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($445.02).
As a Medicare-enrolled provider, Moore has provided services to 781 Medicare beneficiaries, totaling 995 services with total Medicare billing of $73,261. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location St. Louis, MO
- Active Since 10/06/2006
- Last Updated 01/22/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1114014867
Products in Payments
- TALTZ (Drug) $125.00
- TREMFYA (Drug) $74.99
- BENLYSTA (Biological) $36.80
- CELEBREX (Drug) $35.68
- XELJANZ (Drug) $34.59
- OFEV (Drug) $17.91
- ILARIS (Biological) $16.12
- Rinvoq (Biological) $12.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.